As vaccine demand wanes, Singapore Paincare seeks growth from new TCM arm, acquisitions

WITH its newly launched traditional Chinese medicine (TCM) brand, Singapore Paincare Holdings (SPCH) has taken another step towards its goal of building a holistic suite of end-to-end pain care treatment offerings. And Dr Bernard Lee, the company’s chief executive, also hopes the move will help it capture a bigger slice of the niche healthcare pie.

The Catalist-listed medical services group opened an integrated pain care and wellness centre in Singapore in March this year. Dr Lee said in an interview that Singapore Paincare TCM Wellness aims to both integrate TCM with Western treatment interventions and capture a more pro-TCM patient profile.

“We recognise that some patients may only have 70 per cent of their pain alleviated after visiting our other pain treatment clinics,” he said. “They are still looking for that final 30 per cent, and TCM can tweak that outcome.”